StonvexLoading…
StonvexStonvexStonvexCore line items from TSM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $88.27B | $70.60B | $73.67B | $57.22B |
Operating Income | $40.32B | $30.09B | $36.49B | $23.43B |
Net Income | $35.30B | $27.79B | $32.32B | $21.37B |
EPS (Diluted) | $1.36 | $1.07 | $1.25 | $0.82 |
Total Assets | $204.08B | $180.67B | $161.55B | $134.29B |
Total Liabilities | $73.57B | $67.87B | $66.60B | $56.73B |
Cash & Equivalents | $64.89B | $44.69B | $43.85B | $34.66B |
Free Cash Flow OCF − CapEx | $26.54B | $9.54B | $17.18B | $9.84B |
Shares Outstanding | Not available | Not available | Not available | Not available |